Subscribe for News and Updates
Stay informed with the latest news, updates, and episodes from the HeadWise podcast.
Match to clinical trials in 60 seconds
- Know your options
- Access the latest treatments
- Receive world class care
AMMO Digital Therapeutic (DTx) Study
The AMMO digital therapeutic (DTx) study will provide an online based program for participants with migraines after head injury to follow for 12 weeks. This study aims to see if using cognitive behavioral therapy aimed at military service members in an online self administered platform is effective therapy in the relief of migraines compared. The study will use a single blind online comparative program to test the effect.
Lilly Trials
Lilly is currently enrolling participants for multiple migraine research studies for children and teens ages 6 to 17, and your child may be able to take part. These studies are evaluating the safety and effectiveness of investigational medications that are already approved for the treatment of migraine in adults.
Teva Migraine Pregnancy Registry
The Teva Migraine Pregnancy Registry studies the effects of migraine medications during pregnancy. Eligible participants (ages 18-45) can join by completing a short screening. No extra medical visits required.
PROCEED Trial
Lundbeck is conducting the PROCEED Phase IIb clinical trial to evaluate the efficacy and safety of Lu AG09222, an investigational monoclonal antibody targeting PACAP for migraine prevention. The study involves monthly subcutaneous doses over three months. Eligible participants are adults aged 18-65 with a history of migraine. To learn more or determine eligibility, visit the PROCEED study page.
